These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9840700)

  • 1. Modification of human T-cell responses by altered peptide ligands: a new approach to antigen-specific modification.
    Nishimura Y; Chen YZ; Kanai T; Yokomizo H; Matsuoka T; Matsushita S
    Intern Med; 1998 Oct; 37(10):804-17. PubMed ID: 9840700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation.
    Chen YZ; Matsushita S; Nishimura Y
    J Immunol; 1996 Nov; 157(9):3783-90. PubMed ID: 8892606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degenerate recognition and response of human CD4+ Th cell clones: implications for basic and applied immunology.
    Nishimura Y; Chen YZ; Uemura Y; Tanaka Y; Tsukamoto H; Kanai T; Yokomizo H; Yun C; Matsuoka T; Irie A; Matsushita S
    Mol Immunol; 2004 Feb; 40(14-15):1089-94. PubMed ID: 15036913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno-suppressive peptides for a human T cell clone autoreactive to a unique acetylcholine receptor alpha subunit peptide presented by the disease-susceptible HLA-DQ6 in infant-onset myasthenia gravis.
    Kanai T; Nomura Y; Segawa M; Takagi K; Senju S; Matsushita S; Nishimura Y
    Hum Immunol; 1997; 56(1-2):28-38. PubMed ID: 9455491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered peptide ligands of a myasthenogenic epitope as modulators of specific T-cell responses.
    Kirshner SL; Zisman E; Fridkin M; Sela M; Mozes E
    Scand J Immunol; 1996 Nov; 44(5):512-21. PubMed ID: 8947604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell selection and differential activation on structurally related HLA-DR4 ligands.
    Gebe JA; Novak EJ; Kwok WW; Farr AG; Nepom GT; Buckner JH
    J Immunol; 2001 Sep; 167(6):3250-6. PubMed ID: 11544312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique T cell proliferation associated with PKCmu activation and impaired ZAP-70 phosphorylation in recognition of overexpressed HLA/partially agonistic peptide complexes.
    Irie A; Chen YZ; Tsukamoto H; Jotsuka T; Masuda M; Nishimura Y
    Eur J Immunol; 2003 Jun; 33(6):1497-507. PubMed ID: 12778467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA.
    Gedde-Dahl T; Spurkland A; Fossum B; Wittinghofer A; Thorsby E; Gaudernack G
    Eur J Immunol; 1994 Feb; 24(2):410-4. PubMed ID: 7507844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln-->Leu61).
    Gedde-Dahl T; Spurkland A; Eriksen JA; Thorsby E; Gaudernack G
    Int Immunol; 1992 Nov; 4(11):1331-7. PubMed ID: 1282032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered T cell ligands derived from a major house dust mite allergen enhance IFN-gamma but not IL-4 production by human CD4+ T cells.
    Tsitoura DC; Verhoef A; Gelder CM; O'Hehir RE; Lamb JR
    J Immunol; 1996 Sep; 157(5):2160-5. PubMed ID: 8757342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered TCR ligands affect antigen-presenting cell responses: up-regulation of IL-12 by an analogue peptide.
    Matsuoka T; Kohrogi H; Ando M; Nishimura Y; Matsushita S
    J Immunol; 1996 Dec; 157(11):4837-43. PubMed ID: 8943386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactive TCR responses to self antigens presented by different MHC class II molecules.
    Mycko MP; Waldner H; Anderson DE; Bourcier KD; Wucherpfennig KW; Kuchroo VK; Hafler DA
    J Immunol; 2004 Aug; 173(3):1689-98. PubMed ID: 15265898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding.
    Tao X; Grant C; Constant S; Bottomly K
    J Immunol; 1997 May; 158(9):4237-44. PubMed ID: 9126985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
    Ding L; Shevach EM
    J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique T cell antagonist properties of the exact self-correlate of a peptide antigen revealed by self-substitution of non-self-positions in the peptide sequence.
    Schountz T; Kasselman JP; Ford SR; Murray JS
    Cell Immunol; 1996 Mar; 168(2):193-200. PubMed ID: 8640865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
    Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
    J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cells from (New Zealand Black x New Zealand White)F1 lupus mice and normal mice immunized against apoptotic nucleosomes recognize similar Th cell epitopes in the C terminus of histone H3.
    Fournel S; Neichel S; Dali H; Farci S; Maillère B; Briand JP; Muller S
    J Immunol; 2003 Jul; 171(2):636-44. PubMed ID: 12847228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
    Deng C; Goluszko E; Christadoss P
    J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of polyclonal T cell responses by an MHC anchor-substituted variant of myelin oligodendrocyte glycoprotein 35-55.
    Ford ML; Evavold BD
    J Immunol; 2003 Aug; 171(3):1247-54. PubMed ID: 12874212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis.
    Aruna BV; Ben-David H; Sela M; Mozes E
    Immunology; 2006 Jul; 118(3):413-24. PubMed ID: 16827902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.